ADVFN US – Market Content Editor
-
Gold Prices Slip Amid Tariff Relief and Dollar Strength, Despite Lingering Economic Uncertainty
Gold prices dipped during Asian trading on Wednesday, pressured by a growing risk appetite following U.S. President Donald Trump’s decision to delay imposing steep tariffs on the European Union. The move eased some fears of a trade escalation, encouraging investors to favor riskier assets over traditional safe havens like gold. Alongside gold, other metals faced…
-
Bitcoin Holds Steady Near $109K as Legislative Backing Emerges at 2025 Conference
Bitcoin (COIN:BTCUSD) maintained a steady position on Wednesday, hovering just below its recent all-time high as investors closely watched updates from the ongoing Bitcoin 2025 conference in Las Vegas. The world’s leading cryptocurrency was largely flat at around $109,030 as of early Wednesday morning – 01:41 ET. Last Thursday, Bitcoin hit a record peak approaching…
-
Oil Prices Edge Higher Amid Sanction Concerns and Upcoming OPEC+ Meeting
Oil prices experienced a modest rise during Wednesday’s Asian trading session as investors weighed the risks of potential new sanctions on Russia alongside slow progress in nuclear negotiations between the U.S. and Iran. These factors contributed to concerns over possible disruptions in the global oil supply. Meanwhile, market participants remained cautious ahead of a key…
-
Trump’s Delay Of EU Tariffs Sparks Rally On Wall Street
After moving sharply higher early in the session, stocks saw further upside over the course of the trading day on Tuesday. With the strong upward move, the major averages largely offset the steep losses posted last week. The Nasdaq shot up 461.96 points or 2.5 percent to 19,199.16, the S&P 500 (SPI:SP500) surged 118.72 points…
-
NeuroPace Shares Plunge After Mixed Clinical Trial Results
NeuroPace Inc. (NASDAQ:NPCE) saw its stock nosedive by 36.1% today after announcing that its NAUTILUS clinical trial failed to meet its primary effectiveness target across the full patient population. The study was aimed at assessing the RNS System as a treatment for drug-resistant idiopathic generalized epilepsy (IGE). Despite the disappointing topline efficacy results, the study…
-
Eos Energy Shares Drop 10% Following Sudden CFO Departure
Shares of Eos Energy Enterprises Inc. (NASDAQ:EOSE) fell sharply by 10.1% after the abrupt termination of CFO Eric Javidi was announced on May 27, 2025. The company emphasized that Javidi’s departure was “without cause” and unrelated to any financial discrepancies or disagreements. He is expected to receive severance in line with his offer letter. Despite…
-
Eli Lilly Expands Pain Treatment Pipeline with SiteOne Therapeutics Acquisition
Eli Lilly and Company (NYSE:LLY) is advancing its neuroscience portfolio by acquiring SiteOne Therapeutics in a deal valued at up to $1 billion, reinforcing its focus on non-opioid pain therapies. The acquisition centers on SiteOne’s STC-004, a Phase 2-ready Nav1.8 inhibitor designed to provide relief for chronic pain sufferers without the risks of addiction associated…
-
Strategy Shares Gain After Major Bitcoin Purchase
Shares of Strategy (NASDAQ:MSTR), the Bitcoin-focused company led by Michael Saylor, rose 3.6% in premarket trading following news of a substantial Bitcoin acquisition. On Monday, Strategy revealed it had acquired an additional 4,020 Bitcoins at a total cost of $427.1 million. This purchase was financed through the sale of at-the-market perpetual strike preferred stock. This…
-
Rocket Pharmaceuticals Shares Plunge After Patient Death Leads to Trial Suspension
Rocket Pharmaceuticals (NASDAQ:RCKT) saw its stock tumble 57% in premarket trading after reporting a patient death linked to serious adverse effects during a clinical trial. This tragic incident has triggered an in-depth investigation and ongoing discussions with the FDA as the company works to determine the cause of the complication. The patient’s passing was associated…
-
JPMorgan Adopts Bullish Outlook on Crypto Amid Positive Sector Developments
JPMorgan has shifted to a more optimistic stance on digital assets, pointing to several factors that may support growth throughout 2025. “We turn more constructive on digital assets,” strategists led by Nikolaos Panigirtzoglou stated in a Monday note, marking a change after subdued results from crypto hedge funds and CTAs earlier this year. A major…